new post
StocksRunner logo
mail
search
 
menu
 
Aardvark Therapeutic
$5.20
-10.19%
 
  Set Alerts  
  
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 

AARD Stock Analysis & IQ Rating | Aardvark Therapeutics Inc.

 
 

AARD

 

Aardvark Therapeutics Inc

$5.20

 
-$0.59 | -10.19%
 
Set Alerts
 
  Overview  
  
  Comments  
  
  Insights  
  
     Risks     
  
  Rating  
  
     Chart     
  
  Analysts  
  
  Street  
  
  Sentiment  
  
  Headlines  
 
 
52W High
$17.94
 
 
MKT CAP
$112.83M
 
52W Low
$4.74
 
 
VOL
$821.71K
 
P/E Ratio
N/A
 
 
AVG VOL
$318.75K
 
RSI
22.78
 
 
TREND
Downtrend
 
 
 

AARD Stock IQ

 
lock  Login to see Aardvark Therapeutics Inc (AARD) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 

AARD Target Price

 
 
 

Strengths

 
 

AARD Rewards

 Outperform the market

AARD Rewards

 Upgraded on attractively valued

 
 

AARD Price Performance

 
 

$12.67   (-58.96%)

$14.43   (-63.96%)

$13.93   (-62.67%)

$8.99   (-42.16%)

 
 
1year
6month
3month
1month

AARD Analysts Opinion

Overall standing based on market and analyst consensus. menu Hover over the category for more information

Earnings

×

Earnings

Rating

×

Rating

AARD Rating Sentiment Upgraded on attractively valued

Momentum

×

Momentum

AARD Momentum Analysis Price value has negative momentum

Activity

×

Activity

Future

×

Future

AARD Future Sentiment Outperform the market
AARD Analysts Opinion

AARD Analysts opinion is negative and it remained unchanged from the past 3 months

AARD Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

56%
Consensus Rating
100%
Buy
Opinion
50%
Trend
Score
100%
Potential
Score
AARD Street Sentiment

AARD Street Sentiment is bullish and have positive views on the near-term outlook

AARD Risk Level

AARD has Fair risk level

Risk Indicators

Low volume
High volatilty
AARD Risk Level
Fair
LOW
HIGH

AARD Performance Sentiment

Sentiments overview associated with events and the stock performance

56%
Positive
5 out of 9
events present
44%
Negative
4 out of 9
events present
Very Bullish
Bullish
Neutral
Bearish
Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price
$4.90
Resistance Price
$12.61
Current Price Range
$5.79
$4.90
$12.61
Show methods +
 
 

Analyst Consensus

 

Recent Upgrades and Downgrades

 
 
100%
Consensus Rating
STRONG BUY
4
Buy
0
Hold
0
Sell
Date
Action
Rating
Firm

Dec 13, 2025

 

Initiate

 

Outperform

 

William Blair

 

Nov 15, 2025

 

Reiterate

 

Outperform

 

RBC

 

Nov 07, 2025

 

Initiate

 

Buy

 

BTIG

 

Sep 30, 2025

 

Initiate

 

Buy

 

Stifel

 
 
 
AARD Latest Analysis +
 
 
FAQ About AARD Stock Insights
 

What is AARD current stock price?

What are AARD stock strengths?

What is AARD Risk Level?

What is AARD market cap and volume?

What is AARD current Stock IQ?

Should I buy AARD stock right now?

Is AARD a Strong Buy right now?

What does a 'Strong Buy' rating mean for AARD?

What does a 'Strong Sell' rating mean for AARD?

What factors influence AARD's Stock IQ?

 
 
StocksRunner

Explore our AARD Stock insights

  • In-Depth Market Analysis and Trends
  • Expert Insights on Market Dynamics
  • Tailored AARD Stock Strategies
  • Effective Risk Management
 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive our AARD Daily Alerts

Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

 
Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

 
Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

 
About StocksRunner

Log In

Sign Up

Plans & Pricing

Contact Us

Terms of use

Privacy Policy

 
 
 
 

AARD

 

Aardvark Therapeutics Inc

 
Set Alerts
 
 

Current Price

 

$5.20

 
-$0.59 | -10.19%
 
 
52W High
$17.94
 
 
MKT CAP
$112.83M
 
52W Low
$4.74
 
 
VOL
$821.71K
 
P/E Ratio
N/A
 
 
AVG VOL
$318.75K
 
RSI
22.78
 
 
TREND
Downtrend
 
 
 
  Overview  
  
  Comments  
  
  Insights  
  
   Risks   
  
  Rating  
  
  Chart  
  
  Analysts  
  
  Street  
  
  Sentiment  
 
 
 
 
user
 
 
 
 

AARD Price Performance

 
 

$12.67   (-58.96%)

$14.43   (-63.96%)

$13.93   (-62.67%)

$8.99   (-42.16%)

 
 
1year
6month
3month
1month
 

AARD Analysts Opinion

Overall standing per market and analyst expectations. menu Hover over the category for more information

Earnings

×

Earnings

Rating

×

Rating

AARD Rating Sentiment Upgraded on attractively valued

Momentum

×

Momentum

AARD Momentum Sentiment Price value has negative momentum

Activity

×

Activity

Future

×

Future

AARD Future Sentiment Outperform the market
AARD Analysts Opinion

AARD Analysts opinion is negative and it remained unchanged from the past 3 months

AARD Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

56%
Consensus Rating
100%
Buy
Opinion
50%
Trend
Score
100%
Potential
Score
AARD Street Sentiment

AARD Street Sentiment is bullish and have positive views on the near-term outlook

AARD Risk Level

AARD has Fair risk level

Risk Indicators

Low volume
High volatilty
AARD Risk Level
Fair
LOW
HIGH
AARD Performance Sentiment
Sentiments overview associated with events and the stock performance.
56%
Positive
5 out of 9
events present
44%
Negative
4 out of 9
events present
Very Bullish
Bullish
Neutral
Bearish
Very Bearish

Key Price Levels

Average key support and resistance price levels

Support Price
$4.90
Resistance Price
$12.61
Current Price Range
$5.79
$4.90
$12.61
Show methods +

Latest Analyst Actions

Overall Wall Street Rating

100%
Consensus Rating
STRONG BUY
4
Buy
0
Hold
0
Sell
Date
Action
Rating
Firm
Dec 13, 2025
Initiate
Outperform
William Blair
Nov 15, 2025
Reiterate
Outperform
RBC
Nov 07, 2025
Initiate
Buy
BTIG
Sep 30, 2025
Initiate
Buy
Stifel
 
 
 
 

AARD Stock IQ

 
 
 
lock  Login to unlock Aardvark Therapeutics Inc (AARD) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
 
 
 

Target Price

 
 
 
 
 
 
 

Stock Insights

 
 
 
 

Strengths

 
 

AARD Rewards

 Outperform the market

AARD Rewards

 Upgraded on attractively valued

 
 
 

AARD Latest Analysis

 
 
 

OpenAI Launches Codex Security Vulnerability Scanner. OpenAI unveiled Codex Security on Friday an advanced application security tool that detects complex software vulnerabilities. Available in research preview to ChatGPT Enterprise Business and Edu users it is free for the first month.Using OpenAI'.s frontier models Codex Security builds detailed threat models for projects prioritizing real-world risks and reducing false positives allowing security teams to focus on critical issues.Originall

 

Fri Mar 6, 2026

$5.85 | +1.92%
 
Activity

Aardvark Therapeutics stock plunges after trial pause.

 

Mon Mar 2, 2026

$5.47 | -56.20%
 
Momentum

Why Aardvark Therapeutics Just Lost More Than Half Its Value. Biotech stock Aardvark Therapeutics crashed Monday after the company voluntarily stopped its Prader-Willi study.The post Why Aardvark Therapeutics Just Lost More Than Half Its Value appeared first on Investor'.s Business Daily.

 

Mon Mar 2, 2026

$5.47 | -56.20%
 
Momentum

Stock Market Today: S&P 500 Dow Nasdaq Futures Slide Amid US And Israel Operation Epic Furry Against Iran— HKD AARD MDB In Focus (UPDATED). Editor’.s Note: The future prices of benchmark tracking ETFs and the headline were updated in the story.United States stock futures fell sharply on Monday following Friday’.s losses. Futures of the major benchmark indices were negative amid the ongoing Iran-United States conflict.Over the weekend the 86-year-old Iranian Supreme Leader Ayatollah Ali

 

Mon Mar 2, 2026

$5.47 | -56.20%
 
Momentum

Why Is Aardvark Therapeutics Stock Sinking Monday?. Aardvark Therapeutics Inc. (NASDAQ:AARD) shares are down during Monday’.s premarket session following the company’.s announcement to voluntarily pause its Phase 3 HERO trial for Prader-Willi Syndrome.The decision comes as the company is conducting a comprehensive review of safety data.Observed Side EffectsThe company on Friday revealed that it will not announce topline data from the HERO trial as previously anticipated in the third qu

 

Mon Mar 2, 2026

$5.47 | -56.20%
 
Momentum

This Novo Nordisk Analyst Is No Longer ish. Here Are Top 5 Downgrades For Monday. Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes including upgrades downgrades and initiations please see our analyst ratings page.RBC Capital analyst Brian Abrahams downgraded Aardvark Therapeutics Inc (NASDAQ:AARD) from Outperform to Sector Perform and cut the price target from $18 to $6. Aardvark Therapeutics shares closed at $12.49 on Friday. S

 

Mon Mar 2, 2026

$5.47 | -56.20%
 
Potential

Stock Market Today: S&P 500 Dow Jones Futures Slide Amid War Against Iran— AMTD Digital Aardvark MongoDB In Focus. United States stock futures fell sharply on Monday following Friday’.s losses. Futures of the major benchmark indices were negative amid the ongoing Iran-United States conflict.Over the weekend the 86-year-old Iranian Supreme Leader Ayatollah Ali Khamenei was killed in the strikes carried out by Israel and the United States Meanwhile President Donald Trump suggested that the cu

 

Mon Mar 2, 2026

$5.47 | -56.20%
 
Momentum
 
 
 
 
 
StocksRunner

Discover AARD Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of AARD. We're here to help you make informed investment decisions today.

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Receive our AARD Daily Alerts

Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

AARD Stock trends

AARD Stock performance

AARD Stock analysis

AARD investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo
 

AARD Alerts

Real-time signals powered by data
×

Price-Based

Triggers when the stock breaks through a known resistance level
 
Triggers when the stock drops below a key support level
 
Notifies if the stock moves up/down by a set percentage (e.g. ±5%)
 
Alerts when the stock hits a new high or low
 
Signals proximity to long-term highs or lows (e.g. within 5%)
 

Technical Indicator (Pro Plan)

Volume spikes 2x–3x above average. Indicates strong buying/selling pressure
 
Tracks large intraday swings, signaling potential opportunities or risk
 
Signals potential trend reversals or continuations
 
Long-term bullish/bearish trend signals from MA crossovers
 
RSI above 70 or below 30 to identify possible reversals
 
Signals momentum shifts
 

Fundamental Indicator (Master Plan)

Upcoming or just-released earnings reports
 
Alerts after results compared to expectations
 
Changes in rating or target price
 
New or changed dividends
 
Large trades by company insiders
 
M&A, lawsuits, product launches, etc
 
High volume/open interest in call/put contracts
 
Surge in mentions or sentiment shifts
 
 
Cancel
 
×
 
0/666
joker
 
Post
 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing AARD

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

 
✕
 
StocksRunner logo
 

Don't Be a Sheep, Be a StocksRunner

 

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

 
StocksRunner thumbnail
 
 

Sign up for free and

continue analysing AARD

 
Signup to Stocksrunner
 

Already a Member? Click here to Login

 

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.